Friends Research Institute, Inc.
Friends Research Institute, Inc.
Explore linked clinical trials.15 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Supporting Treatment for Opioids and Recovery Capital (STORC) - R61 Phase | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Not applicable | 2026-10-09 | NCT07787039 | |
| Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Muscular Disorders, Atrophic, facioscapulohumeral muscular dystrophy, hereditary disease, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, nervous system disorder, neuromuscular disease | Active, not recruiting | Not stated | 2026-09-17 | NCT03458832 | |
| NOTRE: Optimizing Long-Acting Pre-Exposure Prophylaxis and Medications for Opioid Use Disorder Interventions in Carceral Settings | Blood-Borne Infections, Chemically-Induced Disorders, Genital Diseases, HIV infectious disease, Infections, Narcotic-Related Disorders, Opioid Use Disorder, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, opiate dependence, psychiatric disorder, sexually transmitted disease, substance-related disorder, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Not yet recruiting | Phase 4 | 2026-08-26 | NCT06854029 | |
| Buprenorphine for Individuals in Jail | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Phase 3 | 2026-06-04 | NCT06306443 | |
| Addressing Racial Disparities in Opioid Overdose Using Peer Recovery Coach Training and mHealth Platform | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Not applicable | 2026-05-27 | NCT06573476 | |
| Treating Polysubstance Use Using a Novel Digital Technology | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Active, not recruiting | Phase 3 | 2026-05-19 | NCT05766631 | |
| Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD) | FSHD | Recruiting | Not stated | 2026-05-07 | NCT04635891 | |
| Extended Release Naltrexone Versus Extended Release Buprenorphine With Individuals Leaving Jail | Chemically-Induced Disorders, Narcotic-Related Disorders, opiate dependence, psychiatric disorder, substance-related disorder | Active, not recruiting | Phase 2 / Phase 3 | 2026-05-05 | NCT04408313 | |
| Telemedicine XR-B for Individuals in Jail | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Active, not recruiting | Phase 3 | 2026-04-24 | NCT07524738 | |
| Adaptation and Implementation of an Evidence-based Approach to Advance HIV Prevention and Care | AIDS, Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Not applicable | 2026-04-21 | NCT07495059 | |
| NavSTAR Implementation Effectiveness Trial Across a Health System | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Not applicable | 2025-12-03 | NCT07262190 | |
| Continuum of Care in Hospitalized Patients With Opioid/Stimulant Use Disorder and Infectious Complications From Drug Use | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Not applicable | 2025-10-31 | NCT06513156 | |
| The Youth Opioid Recovery Support (YORS) Intervention | Chemically-Induced Disorders, Narcotic-Related Disorders, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Not applicable | 2025-09-24 | NCT04173416 | |
| Low-dose Versus a High-dose Sublingual Buprenorphine Induction | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Active, not recruiting | Phase 4 | 2025-08-12 | NCT05944952 | |
| Using the Ending Self-Stigma Intervention to Reduce Internalized Stigma Among People Living With HIV Who Use Substances | Chemically-Induced Disorders, Substance Use, psychiatric disorder, substance-related disorder | Active, not recruiting | Not applicable | 2025-07-20 | NCT05704764 |